ロード中...
Combination Nucleoside/ Nucleotide Reverse Transcriptase Inhibitors
INTRODUCTION: The combination of two nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTIs) and a third agent from another antiretroviral class is currently recommended for initial antiretroviral therapy. In general, N(t)RTIs remain relevant in subsequent regimens. There are currently six...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3397780/ https://ncbi.nlm.nih.gov/pubmed/22149368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2012.642865 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|